ConductScience.org, home

Paper8450671

Altered properties of human T-lymphoblast soluble low Km 5'-nucleotidase: comparison with B-lymphoblast enzyme.

Madrid-Marina V and 4 others. Leuk Res, 1993. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Altered properties of human T-lymphoblast soluble low Km 5'-nucleotidase: comparison with B-lymphoblast enzyme. Papers, record 8450671. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8450671

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Altered properties of human T-lymphoblast soluble low Km 5'-nucleotidase: comparison with B-lymphoblast enzyme.
PubMed
Journal
Leuk Res
PubMed
Year
1993
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.17
iCite
Revised in PubMed
2019-08-25
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Madrid-Marina VV
2Lestan BB
3Nowak PJP J
4Fox IHI H
5Spychala JJ

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
5'-NucleotidaseMajor topic
B-LymphocytesMajor topic
IsoenzymesMajor topic
T-LymphocytesMajor topic
Blotting, Western
Cations, Divalent
Cells, Cultured
Cytoplasm
Humans
Hydrogen-Ion Concentration
Kinetics
Macromolecular Substances
Molecular Weight
Substrate Specificity

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
2 RO1 AM19674NIADDK NIH HHSUnited StatesR01AM019674PubMed and NIHNIH RePORTER
5MO1 RR42NCRR NIH HHSUnited StatesPubMedPubMed
FO5 TWO3371FIC NIH HHSUnited StatesPubMedPubMed
F05TW003371NIHNIH RePORTER

Download CSV of grants

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
31547393Purine-Metabolising Enzymes and Apoptosis in Cancer.Cancers (Basel)2019https://conductscience.org/library/papers/31547393PubMed
18279955Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H.Leuk Res2008https://conductscience.org/library/papers/18279955PubMed
11417472Nucleoside analogues: mechanisms of drug resistance and reversal strategies.Leukemia2001https://conductscience.org/library/papers/11417472PubMed
8615751Structure-activity relationship of cytoplasmic 5'-nucleotidase substrate sites.Biochem J1996https://conductscience.org/library/papers/8615751PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NT5E4907PubTator's text mininghttps://conductscience.org/library/genes/4907

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8450671

GET https://conductscience.org/api/papers/v1/8450671/authors